Paul J. Ross

King's College Hospital NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

61h-index23.4kcitations396works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(143), Colorectal Cancer Treatments and Studies(86), Renal cell carcinoma treatment(72), Pancreatic and Hepatic Oncology Research(69), Cancer Immunotherapy and Biomarkers(64)

Publications394 total

Setting the Record Straight: Utility and Outcomes in Patients With <scp>HCV</scp> Related <scp>HCC</scp>
Journal of Viral Hepatitis·2026Open Access
Pattern of progression and post-progression survival following transarterial embolization. A analysis of the TACE-2 and TACTICS trials.
JHEP Reports·2026Open Access
Advanced ampullary cancer: post-hoc analysis of the ABC-01, ABC-02, and ABC-03 clinical trials
The Oncologist·2025Open Access
Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1
Journal for ImmunoTherapy of Cancer·2025Open Access
Real world outcomes for patients with high grade neuroendocrine neoplasms at Guy's Cancer Centre
Endocrine Abstracts·2025
25P Reflex molecular biomarker testing in colorectal cancer: Pathway insights from the South-East England network
Annals of Oncology·2025Open Access
Guy’s Cancer Cohort: Guy’s Cancer Centre’s Real-World Evidence Programme 5 years later
ESMO Real World Data and Digital Oncology·2025Open Access
FRI-102 Selective internal radiation therapy (SIRT) for HCC: real-world experience from a tertiary care center
Journal of Hepatology·2025
Implementation of mass pharmacogenetic testing<i>: Dihydropyrimidine dehydrogenase</i> testing prior to fluoropyrimidine treatment for patients
British Journal of Clinical Pharmacology·2025· 3 citedOpen Access
A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer
Journal of Hepatology·2025· 7 citedOpen Access
UK cancer vaccine advance – Recognising and realising opportunities
Cambridge Prisms Precision Medicine·2025Open Access
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
Journal of Clinical Oncology·2024· 19 citedOpen Access
Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice
Journal of Clinical Oncology·2024· 9 citedOpen Access
P115 Radiological-histological discordance may predict outcomes in patients transplanted for HCC
2024
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study
Journal of Clinical Oncology·2024· 64 citedOpen Access
Supplementary Table S1 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study
2024Open Access
Supplementary Figure S3 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study
2024Open Access
Supplementary Figure S10 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study
2024Open Access
Supplementary Table S10 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study
2024Open Access
Supplementary Figure S7 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study
2024Open Access
page 1 of 20Next →

Frequent Co-authors

David Cunningham(28), Juan W. Valle(14), Daniel H. Palmer(13), Harpreet Wasan(13), Stephen Falk(11), Timothy Iveson(11), Jonathan Wadsley(10), Yuk Ting(10), John Bridgewater(10), Tamas Hickish(9), Ian Chau(8), John P. Neoptolemos(7), Alan Anthoney(7), A. Norman(7), John Primrose(6), Pippa Corrie(6), Mark Hill(6), Roopinder Gillmore(5), Gary Middleton(5), Kinnari Patel(5)